Viewing Study NCT05700669


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-05-17 @ 2:04 PM
Study NCT ID: NCT05700669
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2022-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors
Sponsor: Valerio Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
None Recurrent Epithelial Ovarian Cancer View
None Breast Cancer View
Keywords: